N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

VisionApp - Ghosting

Sponsor: Indiana University • ClinicalTrials.gov ID: NCT07571538

Registry updated: 2026-08-24
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such technology by VisionApp, specifically with regard to ghosting vision. VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).

Interventions

  • Proclear 1 Day Contact Lens (Device)
    Proclear 1 day is a commercially available single vision soft contact lens for single use (daily wear). Participants will wear these contacts at the beginning of the study visit to establish best corrected vision. Participants will then continue to wear this contact lens in one eye for the duration of the study visit.
  • MyDay Contact Lens (Device)
    MyDay is a commercially available multifocal soft contact lens for daily wear. Adult participants will assess images for ghosting while wearing a MyDay contact lens in one eye. Order of exposure to this lens will be determined via randomization.
  • NaturalVue Contact Lens (Device)
    NaturalVue is a commercially available multifocal soft contact lens for daily wear. Adult participants will assess images for ghosting while wearing a NaturalVue contact lens in one eye. Order of exposure to this lens will be determined via randomization.
  • MiSight 1 Day Contact Lens (Device)
    MiSight 1 Day is a commercially available multifocal soft contact lens for daily wear. Children participants will assess images for ghosting while wearing a MiSight 1 Day contact lens in one eye. Order of exposure to this lens will be determined via randomization.
  • Investigational Contact Lens (Device)
    An investigational multifocal soft contact lens for daily wear. While the contact lens is made of an FDA approved material which is already marketed in the United States, it differs from commercially available lenses in that it has a slightly different optical design. Children participants will assess images for ghosting while wearing this investigational contact lens in one eye. Order of exposure to this lens will be determined via randomization.
  • VisionApp (Device)
    VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc.)

Eligibility criteria

Inclusion Criteria: * has a refractive error between Plano and -5.00 D of sphere and cylinder components combined. * has refractive cylinder (e.g., astigmatism) of -0.75 D or less * has had a self-reported oculo-visual exam in the last 2 years * has best-corrected visual acuity of at least 20/20 in each eye * is not amblyopic or does not have any diagnosed ocular disease * is willing and able to follow instructions and maintain the appointment schedule Exclusion Criteria: * has any systemic disease affecting ocular health and visual acuity * is currently using any systemic or topical medications that could affect ocular health and visual acuity * is participating in another eye related research study

Conditions

Diplopia, Monocular

Locations

  • Clinical Optics Research Lab — Bloomington, Indiana, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record